References
- Billiottet J., Ferrand J. Un nouveau vaso-dilatateur et anti-spasmodique de synthèse: Le Caa 40; premiers résultats en thérapeutique vasculaire. Semaine Médicale Professionnelle et Médico-Sociale 1958; 34: 635–637
- Birch J., Brånemark P.-J., Nilson K., Lundskog J., Ekholm R. The revascularization of a free full thickness skin graft. Scand J Plast Reconstr Surg., In press
- Castro C. M., Grois M., Grilli H. A new arterial vasodilator: Duvadilan. La Prensa Medica Argentina 1959; 46: 2459–2466
- Jourdan F., Faucon G. Actions vasculaires, périphérique et cérébrale, d'un dérivé de la phénoxy-éthylamine: Le Caa 40. Therapie 1959; 14: 1075–1085
- Landis E. M. Capillary pressure and capillary permeability. Physiol Rev 1934; 14: 404–481
- Lish P. M., Dungan K. W., Peters F. L. A survey of the effects of isoxsuprine on nonvascular smooth muscle. J Pharmacol Exp Ther 1960; 129: 191–199
- Lish P. M., Hillyard I. W., Dungan K. W. The uterine relaxant properties of isoxsuprine. J Pharmacol Exp Ther 1960; 129: 438–444
- Odén B. Microlymphangiographic studies of experimental skin autografts. Acta Chir Scand 1961; 121: 219–232
- Samuels S. S., Shaftel H. E. Use of a new vasodilator agent in the management of peripheral arterial insufficiency. JAM4 1959; 171: 142–145
- Warenbourg H., Pruvot P., Sueur A., Lekieffre J. An experimental study of a vasodilator drug. Caa 40. Its effect on the vascularization of the brain, on the arterial blood pressure, and on the electroencephalogram. Therapie 1961; 314–321
- Weikel J. H., Jr, Wheeler A. G., Joiner P. D. Toxicology absorption and Physiological disposition, of isoxsuprine (vasdilan). Toxicology and Applied Pharmacology 1959; 1: 579–589
- Whittier J. R. Vasorelaxant drugs and cerebrovascular disease. Angiology 1964; 15: 82–87